Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond

Abstract The present worldwide pandemic of coronavirus disease 2019 (COVID‐19) has highlighted the important function of angiotensin‐converting enzyme 2 (ACE2) as a receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) entry. A deeper understanding of ACE2 could offer insights into the mechanisms of SARS‐CoV‐2 infection. While ACE2 is subject to regulation by various factors in vivo, current research in this area is insufficient to fully elucidate the corresponding pathways of control. Posttranslational modification (PTM) is a powerful tool for broadening the variety of proteins. The PTM study of ACE2 will help us to make up for the deficiency in the regulation of protein synthesis and translation. However, research on PTM‐related aspects of ACE2 remains limited, mostly focused on glycosylation. Accordingly, a comprehensive review of ACE2 PTMs could help us better understand the infection process and provide a basis for the treatment of COVID‐19 and beyond.